| Year |
Citation |
Score |
| 2024 |
Beard DJ, Brown LS, Morris GP, Couch Y, Adriaanse BA, Karali CS, Schneider AM, Howells DW, Redzic ZB, Sutherland BA, Buchan AM. Rapamycin Treatment Reduces Brain Pericyte Constriction in Ischemic Stroke. Translational Stroke Research. PMID 39331260 DOI: 10.1007/s12975-024-01298-x |
0.416 |
|
| 2024 |
Mergenthaler P, Balami JS, Neuhaus AA, Mottahedin A, Albers GW, Rothwell PM, Saver JL, Young ME, Buchan AM. Stroke in the Time of Circadian Medicine. Circulation Research. 134: 770-790. PMID 38484031 DOI: 10.1161/CIRCRESAHA.124.323508 |
0.418 |
|
| 2023 |
Mandeville ET, Buchan AM, Tiedt S. Not open and shut: Complex and prolonged blood-brain barrier responses after stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X231216153. PMID 38000041 DOI: 10.1177/0271678X231216153 |
0.343 |
|
| 2023 |
Schneider AM, Neuhaus AA, Hadley G, Balami JS, Harston GW, DeLuca GC, Buchan AM. Posterior circulation ischaemic stroke diagnosis and management. Clinical Medicine (London, England). 23: 219-227. PMID 37236792 DOI: 10.7861/clinmed.2022-0499 |
0.333 |
|
| 2023 |
Schneider AM, Neuhaus AA, Hadley G, Balami JS, Harston GW, DeLuca GC, Buchan AM. Posterior circulation ischaemic stroke diagnosis and management. Clinical Medicine (London, England). 23: 219-227. PMID 37236792 DOI: 10.7861/clinmed.2022-0499 |
0.333 |
|
| 2022 |
Schneider AM, Regenhardt RW, Dmytriw AA, Patel AB, Hirsch JA, Buchan AM. Cerebroprotection in the endovascular era: an update. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 36600581 DOI: 10.1136/jnnp-2022-330379 |
0.353 |
|
| 2022 |
Walther J, Kirsch EM, Hellwig L, Schmerbeck SS, Holloway PM, Buchan AM, Mergenthaler P. Reinventing the Penumbra - the Emerging Clockwork of a Multi-modal Mechanistic Paradigm. Translational Stroke Research. PMID 36219377 DOI: 10.1007/s12975-022-01090-9 |
0.381 |
|
| 2022 |
Neuhaus AA, Buchan AM. Expanding horizons in the endovascular treatment of stroke: larger cores and adjunct thrombolytics. Cardiovascular Research. 118: e91-e95. PMID 36165895 DOI: 10.1093/cvr/cvac145 |
0.389 |
|
| 2022 |
Tiedt S, Buchan AM, Dichgans M, Lizasoain I, Moro MA, Lo EH. The neurovascular unit and systemic biology in stroke - implications for translation and treatment. Nature Reviews. Neurology. 18: 597-612. PMID 36085420 DOI: 10.1038/s41582-022-00703-z |
0.405 |
|
| 2021 |
Buchan AM, Pelz DM. Neuroprotection in Acute Ischemic Stroke: A Brief Review. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 49: 741-745. PMID 34526172 DOI: 10.1017/cjn.2021.223 |
0.429 |
|
| 2021 |
Rothwell PM, Buchan AM. A new thrombolytic drug for acute ischaemic stroke. The Lancet. Neurology. 20: 687-689. PMID 34418384 DOI: 10.1016/S1474-4422(21)00256-8 |
0.354 |
|
| 2021 |
Lo EH, Albers GW, Dichgans M, Donnan G, Esposito E, Foster R, Howells DW, Huang YG, Ji X, Klerman EB, Lee S, Li W, Liebeskind DS, Lizasoain I, Mandeville ET, ... ... Buchan AM, et al. Circadian Biology and Stroke. Stroke. STROKEAHA120031742. PMID 33940951 DOI: 10.1161/STROKEAHA.120.031742 |
0.383 |
|
| 2020 |
Sutherland BA, Hadley G, Alexopoulou Z, Lodge TA, Neuhaus AA, Couch Y, Kalajian N, Morten KJ, Buchan AM. Growth Differentiation Factor-11 Causes Neurotoxicity During Ischemia . Frontiers in Neurology. 11: 1023. PMID 33013673 DOI: 10.3389/Fneur.2020.01023 |
0.337 |
|
| 2020 |
Beard DJ, Li Z, Schneider AM, Couch Y, Cipolla MJ, Buchan AM. Rapamycin Induces an eNOS (Endothelial Nitric Oxide Synthase) Dependent Increase in Brain Collateral Perfusion in Wistar and Spontaneously Hypertensive Rats. Stroke. STROKEAHA120029781. PMID 32772681 DOI: 10.1161/Strokeaha.120.029781 |
0.368 |
|
| 2020 |
Popkirov S, Stone J, Buchan AM. Functional Neurological Disorder: A Common and Treatable Stroke Mimic. Stroke. STROKEAHA120029076. PMID 32295508 DOI: 10.1161/Strokeaha.120.029076 |
0.453 |
|
| 2019 |
Hadley G, Beard DJ, Alexopoulou Z, Sutherland BA, Buchan AM. Investigation of the novel mTOR inhibitor AZD2014 in neuronal ischemia. Neuroscience Letters. PMID 31100427 DOI: 10.1016/J.Neulet.2019.05.023 |
0.398 |
|
| 2018 |
Harston G, Grunwald I, Buchan A. Letter by Harston et al Regarding Article, "Alberta Stroke Program Early CT Score Versus Computed Tomographic Perfusion to Predict Functional Outcome After Successful Reperfusion in Acute Ischemic Stroke". Stroke. STROKEAHA118023749. PMID 30580743 DOI: 10.1161/Strokeaha.118.023749 |
0.474 |
|
| 2018 |
Beard DJ, Hadley G, Thurley N, Howells DW, Sutherland BA, Buchan AM. The effect of rapamycin treatment on cerebral ischemia: A systematic review and meta-analysis of animal model studies. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493018816503. PMID 30489210 DOI: 10.1177/1747493018816503 |
0.418 |
|
| 2018 |
Hadley G, Beard DJ, Couch Y, Neuhaus AA, Adriaanse BA, DeLuca GC, Sutherland BA, Buchan AM. Rapamycin in ischemic stroke: Old drug, new tricks? Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18807309. PMID 30334673 DOI: 10.1177/0271678X18807309 |
0.461 |
|
| 2018 |
Balami J, Coughlan D, McMeekin P, White P, Flynn D, Roffe C, Wiggam I, Flynn P, Chembala J, Natarajan I, Dixit A, Hunter A, Foddy L, Hopkins E, Lumley H, ... ... Buchan A, et al. Case costing of mechanical thrombectomy for acute ischaemic stroke in routine clinical setting:: cost differences between mothership vs drip and ship International Journal of Stroke. 13: 45-46. DOI: 10.1177/1747493018801108 |
0.393 |
|
| 2017 |
Balami JS, White PM, McMeekin PJ, Ford GA, Buchan AM. Complications of endovascular treatment for acute ischemic stroke: Prevention and management. International Journal of Stroke : Official Journal of the International Stroke Society. 1747493017743051. PMID 29171362 DOI: 10.1177/1747493017743051 |
0.463 |
|
| 2017 |
Couch Y, Akbar N, Roodselaar J, Evans MC, Gardiner C, Sargent I, Romero IA, Bristow A, Buchan AM, Haughey N, Anthony DC. Circulating endothelial cell-derived extracellular vesicles mediate the acute phase response and sickness behaviour associated with CNS inflammation. Scientific Reports. 7: 9574. PMID 28851955 DOI: 10.1038/S41598-017-09710-3 |
0.489 |
|
| 2017 |
Neuhaus AA, Couch Y, Hadley G, Buchan AM. Neuroprotection in stroke: the importance of collaboration and reproducibility. Brain : a Journal of Neurology. PMID 28641383 DOI: 10.1093/Brain/Awx126 |
0.532 |
|
| 2017 |
Couch Y, Akbar N, Davis S, Fischer R, Dickens AM, Neuhaus AA, Burgess AI, Rothwell PM, Buchan AM. Inflammatory Stroke Extracellular Vesicles Induce Macrophage Activation. Stroke. PMID 28536169 DOI: 10.1161/Strokeaha.117.017236 |
0.467 |
|
| 2017 |
Howarth C, Sutherland BA, Choi HB, Martin C, Lind BL, Khennouf L, LeDue JM, Pakan JM, Ko RW, Ellis-Davies GC, Lauritzen MJ, Sibson NR, Buchan AM, MacVicar BA. A critical role for astrocytes in hypercapnic vasodilation in brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28137973 DOI: 10.1523/Jneurosci.0005-16.2016 |
0.321 |
|
| 2017 |
Kongbunkiat K, Wilson D, Kasemsap N, Tiamkao S, Jichi F, Palumbo V, Hill MD, Buchan AM, Jung S, Mattle HP, Henninger N, Werring DJ. Leukoaraiosis, intracerebral hemorrhage, and functional outcome after acute stroke thrombolysis. Neurology. PMID 28130468 DOI: 10.1212/Wnl.0000000000003605 |
0.44 |
|
| 2016 |
Nagel S, Sinha D, Day D, Reith W, Chapot R, Papanagiotou P, Warburton EA, Guyler P, Tysoe S, Fassbender K, Walter S, Essig M, Heidenrich J, Konstas AA, Harrison M, ... ... Buchan AM, et al. e-ASPECTS software is non-inferior to neuroradiologists in applying the ASPECT score to computed tomography scans of acute ischemic stroke patients. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 27899743 DOI: 10.1177/1747493016681020 |
0.454 |
|
| 2016 |
Sutherland BA, Fordsmann JC, Martin C, Neuhaus AA, Witgen BM, Piilgaard H, Lønstrup M, Couch Y, Sibson NR, Lauritzen M, Buchan AM. Multi-modal assessment of neurovascular coupling during cerebral ischaemia and reperfusion using remote middle cerebral artery occlusion. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27629101 DOI: 10.1177/0271678X16669512 |
0.359 |
|
| 2016 |
Neuhaus AA, Couch Y, Sutherland BA, Buchan AM. Novel method to study pericyte contractility and responses to ischaemia in vitro using electrical impedance. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27418036 DOI: 10.1177/0271678X16659495 |
0.356 |
|
| 2016 |
Arba F, Palumbo V, Boulanger JM, Pracucci G, Inzitari D, Buchan AM, Hill MD. Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis. International Journal of Stroke : Official Journal of the International Stroke Society. 11: 62-7. PMID 26763021 DOI: 10.1177/1747493015607517 |
0.511 |
|
| 2016 |
Arba F, Palumbo V, Boulanger JM, Pracucci G, Inzitari D, Buchan AM, Hill MD. Leukoaraiosis and lacunes are associated with poor clinical outcomes in ischemic stroke patients treated with intravenous thrombolysis International Journal of Stroke. 11: 62-67. DOI: 10.1177/1747493015607517 |
0.406 |
|
| 2015 |
Sutherland BA, Neuhaus AA, Couch Y, Balami JS, DeLuca GC, Hadley G, Harris SL, Grey AN, Buchan AM. The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26661175 DOI: 10.1177/0271678X15606722 |
0.448 |
|
| 2015 |
Buchan AM, Karbalai HG, Sutherland BA. The future of stroke therapy must not be mired by past arguments The Lancet. 386: 654. PMID 26334159 DOI: 10.1016/S0140-6736(15)61503-3 |
0.473 |
|
| 2015 |
Balami JS, Sutherland BA, Edmunds LD, Grunwald IQ, Neuhaus AA, Hadley G, Karbalai H, Metcalf KA, DeLuca GC, Buchan AM. A systematic review and meta-analysis of randomized controlled trials of endovascular thrombectomy compared with best medical treatment for acute ischemic stroke. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 26310289 DOI: 10.1111/Ijs.12618 |
0.485 |
|
| 2015 |
Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. Reply: Intravenous thrombolysis for ischaemic strokes: A call for reappraisal Brain. 138: e342. PMID 25281865 DOI: 10.1093/Brain/Awu283 |
0.376 |
|
| 2015 |
Redzic ZB, Rabie T, Sutherland BA, Buchan AM. Differential effects of paracrine factors on the survival of cells of the neurovascular unit during oxygen glucose deprivation International Journal of Stroke. 10: 407-414. DOI: 10.1111/Ijs.12197 |
0.301 |
|
| 2014 |
Chen RL, Ogunshola OO, Yeoh KK, Jani A, Papadakis M, Nagel S, Schofield CJ, Buchan AM. HIF prolyl hydroxylase inhibition prior to transient focal cerebral ischaemia is neuroprotective in mice. Journal of Neurochemistry. PMID 24974727 DOI: 10.1111/Jnc.12804 |
0.376 |
|
| 2014 |
Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. Reply: Thrombolysis in acute ischaemic stroke Brain. 137: e282. PMID 24727568 DOI: 10.1093/Brain/Awu066 |
0.441 |
|
| 2014 |
Hall CN, Reynell C, Gesslein B, Hamilton NB, Mishra A, Sutherland BA, O'Farrell FM, Buchan AM, Lauritzen M, Attwell D. Capillary pericytes regulate cerebral blood flow in health and disease. Nature. 508: 55-60. PMID 24670647 DOI: 10.1038/Nature13165 |
0.318 |
|
| 2014 |
Neuhaus AA, Rabie T, Sutherland BA, Papadakis M, Hadley G, Cai R, Buchan AM. Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke Jama Neurology. 71: 634-639. PMID 24590416 DOI: 10.1001/Jamaneurol.2013.6299 |
0.523 |
|
| 2014 |
Sutherland BA, Rabie T, Buchan AM. Laser doppler flowmetry to measure changes in cerebral blood flow Methods in Molecular Biology. 1135: 237-248. PMID 24510869 DOI: 10.1007/978-1-4939-0320-7_20 |
0.35 |
|
| 2014 |
Young CC, Al-Dalahmah O, Lewis NJ, Brooks KJ, Jenkins MM, Poirier F, Buchan AM, Szele FG. Blocked angiogenesis in Galectin-3 null mice does not alter cellular and behavioral recovery after middle cerebral artery occlusion stroke. Neurobiology of Disease. 63: 155-64. PMID 24269916 DOI: 10.1016/J.Nbd.2013.11.003 |
0.801 |
|
| 2013 |
Balami JS, Hadley G, Sutherland BA, Karbalai H, Buchan AM. The exact science of stroke thrombolysis and the quiet art of patient selection Brain. 136: 3528-3553. PMID 24038074 DOI: 10.1093/Brain/Awt201 |
0.531 |
|
| 2013 |
Sutherland BA, Buchan AM. Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat Journal of Cerebral Blood Flow and Metabolism. 33: E1-E7. PMID 23963368 DOI: 10.1038/Jcbfm.2013.148 |
0.472 |
|
| 2013 |
Hadley G, De Luca GC, Papadakis M, Buchan AM. Endogenous neuroprotection: Hamartin modulates an austere approach to staying alive in a recession International Journal of Stroke. 8: 449-450. PMID 23879750 DOI: 10.1111/Ijs.12130 |
0.398 |
|
| 2013 |
Balami JS, Chen RL, Buchan AM. Stroke syndromes and clinical management. Qjm : Monthly Journal of the Association of Physicians. 106: 607-15. PMID 23483140 DOI: 10.1093/qjmed/hct057 |
0.37 |
|
| 2013 |
Papadakis M, Hadley G, Xilouri M, Hoyte LC, Nagel S, McMenamin MM, Tsaknakis G, Watt SM, Drakesmith CW, Chen R, Wood MJ, Zhao Z, Kessler B, Vekrellis K, Buchan AM. Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nature Medicine. 19: 351-7. PMID 23435171 DOI: 10.1038/Nm.3097 |
0.414 |
|
| 2013 |
Balami JS, Sutherland BA, Buchan AM. Complications associated with recombinant tissue plasminogen activator therapy for acute Ischaemic stroke Cns and Neurological Disorders - Drug Targets. 12: 155-169. PMID 23394532 DOI: 10.2174/18715273112119990050 |
0.463 |
|
| 2013 |
Balami JS, Chen R, Sutherland BA, Buchan AM. Thrombolytic agents for acute ischaemic stroke treatment: The past, present and future Cns and Neurological Disorders - Drug Targets. 12: 145-154. PMID 23394531 DOI: 10.2174/18715273113129990057 |
0.482 |
|
| 2013 |
Hill MD, Kenney C, Dzialowski I, Boulanger JM, Demchuk AM, Barber PA, Watson TW, Weir NU, Buchan AM. Tissue Window in Stroke Thrombolysis study (TWIST): a safety study. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 40: 17-20. PMID 23250122 DOI: 10.1017/S0317167100012890 |
0.528 |
|
| 2013 |
Young CC, van der Harg JM, Lewis NJ, Brooks KJ, Buchan AM, Szele FG. Ependymal ciliary dysfunction and reactive astrocytosis in a reorganized subventricular zone after stroke. Cerebral Cortex (New York, N.Y. : 1991). 23: 647-59. PMID 22414771 DOI: 10.1093/Cercor/Bhs049 |
0.807 |
|
| 2013 |
Balami JS, Chen RL, Buchan AM. Stroke syndromes and clinical management Qjm. 106: 607-615. DOI: 10.1093/Qjmed/Hct057 |
0.472 |
|
| 2012 |
Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Neuroprotection for stroke: current status and future perspectives. International Journal of Molecular Sciences. 13: 11753-11772. PMID 23109881 DOI: 10.3390/ijms130911753 |
0.429 |
|
| 2012 |
Nagel S, Hadley G, Pfleger K, Grond-Ginsbach C, Buchan AM, Wagner S, Papadakis M. Suppression of the inflammatory response by diphenyleneiodonium after transient focal cerebral ischemia Journal of Neurochemistry. 123: 98-107. PMID 23050647 DOI: 10.1111/J.1471-4159.2012.07948.X |
0.319 |
|
| 2012 |
Chen RL, Nagel S, Papadakis M, Bishop T, Pollard P, Ratcliffe PJ, Pugh CW, Buchan AM. Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: Insights from genetically modified mice Journal of Physiology. 590: 4079-4091. PMID 22615432 DOI: 10.1113/Jphysiol.2012.232884 |
0.345 |
|
| 2012 |
Rothwell PM, Buchan AM. Mobile acute stroke units: bringing the hospital to the patient. The Lancet. Neurology. 11: 382-3. PMID 22497930 DOI: 10.1016/S1474-4422(12)70069-8 |
0.443 |
|
| 2012 |
Dzialowski I, Puetz V, Buchan AM, Demchuk AM, Hill MD. Does the application of X-ray contrast agents impair the clinical effect of intravenous recombinant tissue-type plasminogen activator in acute ischemic stroke patients? Stroke. 43: 1567-1571. PMID 22496336 DOI: 10.1161/Strokeaha.112.651737 |
0.429 |
|
| 2012 |
Sutherland BA, Minnerup J, Balami JS, Arba F, Buchan AM, Kleinschnitz C. Neuroprotection for ischaemic stroke: Translation from the bench to the bedside International Journal of Stroke. 7: 407-418. PMID 22394615 DOI: 10.1111/J.1747-4949.2012.00770.X |
0.532 |
|
| 2012 |
Nagel S, Papadakis M, Pfleger K, Grond-Ginsbach C, Buchan AM, Wagner S. Microarray analysis of the global gene expression profile following hypothermia and transient focal cerebral ischemia Neuroscience. 208: 109-122. PMID 22366221 DOI: 10.1016/J.Neuroscience.2012.01.048 |
0.313 |
|
| 2012 |
Balami JS, Buchan AM. Complications of intracerebral haemorrhage The Lancet Neurology. 11: 101-118. PMID 22172625 DOI: 10.1016/S1474-4422(11)70264-2 |
0.451 |
|
| 2012 |
Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C. Neuroprotection for stroke: Current status and future perspectives International Journal of Molecular Sciences. 13: 11753-11772. DOI: 10.3390/Ijms130911753 |
0.521 |
|
| 2012 |
Montagu A, Reckless IP, Buchan AM. Stroke: Management and prevention Medicine (United Kingdom). 40: 490-499. DOI: 10.1016/J.Mpmed.2016.06.003 |
0.498 |
|
| 2011 |
Sutherland BA, Papadakis M, Chen RL, Buchan AM. Cerebral blood flow alteration in neuroprotection following cerebral ischaemia. The Journal of Physiology. 589: 4105-14. PMID 21708904 DOI: 10.1113/jphysiol.2011.209601 |
0.308 |
|
| 2011 |
Balami JS, Chen RL, Grunwald IQ, Buchan AM. Neurological complications of acute ischaemic stroke The Lancet Neurology. 10: 357-371. PMID 21247806 DOI: 10.1016/S1474-4422(10)70313-6 |
0.439 |
|
| 2011 |
Grunwald IQ, Wakhloo AK, Walter S, Molyneux AJ, Byrne JV, Nagel S, Kühn AL, Papadakis M, Fassbender K, Balami JS, Roffi M, Sievert H, Buchan A. Endovascular stroke treatment today. Ajnr. American Journal of Neuroradiology. 32: 238-43. PMID 21233233 DOI: 10.3174/Ajnr.A2346 |
0.476 |
|
| 2011 |
Shobha N, Buchan AM, Hill MD. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset - Evidence from the Canadian alteplase for stroke effectiveness study (CASES) registry Cerebrovascular Diseases. 31: 223-228. PMID 21178345 DOI: 10.1159/000321893 |
0.44 |
|
| 2011 |
Young CC, Brooks KJ, Buchan AM, Szele FG. Cellular and molecular determinants of stroke-induced changes in subventricular zone cell migration. Antioxidants & Redox Signaling. 14: 1877-88. PMID 20673127 DOI: 10.1089/Ars.2010.3435 |
0.804 |
|
| 2011 |
Nagel S, Papadakis M, Chen R, Hoyte LC, Brooks KJ, Gallichan D, Sibson NR, Pugh C, Buchan AM. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 132-43. PMID 20407463 DOI: 10.1038/Jcbfm.2010.60 |
0.353 |
|
| 2011 |
Sutherland BA, Papadakis M, Chen RL, Buchan AM. Cerebral blood flow alteration in neuroprotection following cerebral ischaemia Journal of Physiology. 589: 4105-4114. DOI: 10.1113/Jphysiol.2011.209601 |
0.42 |
|
| 2010 |
Harston GWJ, Sutherland BA, Kennedy J, Buchan AM. The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: A review of rtPA neurotoxicity Journal of Cerebral Blood Flow and Metabolism. 30: 1804-1816. PMID 20736961 DOI: 10.1038/Jcbfm.2010.149 |
0.478 |
|
| 2010 |
Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, et al. Stroke: working toward a prioritized world agenda. International Journal of Stroke : Official Journal of the International Stroke Society. 5: 238-56. PMID 20636706 DOI: 10.1111/j.1747-4949.2010.00442.x |
0.428 |
|
| 2010 |
Mateen FJ, Buchan AM, Hill MD. Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians Stroke. 41: 1833-1835. PMID 20576948 DOI: 10.1161/Strokeaha.110.586438 |
0.499 |
|
| 2010 |
Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, et al. Stroke: working toward a prioritized world agenda. Cerebrovascular Diseases (Basel, Switzerland). 30: 127-47. PMID 20516682 DOI: 10.1159/000315099 |
0.52 |
|
| 2010 |
Hachinski V, Donnan GA, Gorelick PB, Hacke W, Cramer SC, Kaste M, Fisher M, Brainin M, Buchan AM, Lo EH, Skolnick BE, Furie KL, Hankey GJ, Kivipelto M, Morris J, et al. Stroke: working toward a prioritized world agenda. Stroke; a Journal of Cerebral Circulation. 41: 1084-99. PMID 20498453 DOI: 10.1161/Strokeaha.110.586156 |
0.52 |
|
| 2010 |
Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM. Ischemic stroke in the elderly: An overview of evidence Nature Reviews Neurology. 6: 256-265. PMID 20368741 DOI: 10.1038/Nrneurol.2010.36 |
0.534 |
|
| 2010 |
Geraghty OC, Kennedy J, Chandratheva A, Marquardt L, Buchan AM, Rothwell PM. Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naïve patients in the acute phase after TIA or minor ischaemic stroke. Cerebrovascular Diseases (Basel, Switzerland). 29: 460-7. PMID 20299785 DOI: 10.1159/000297961 |
0.369 |
|
| 2010 |
Hoyte LC, Brooks KJ, Nagel S, Akhtar A, Chen R, Mardiguian S, McAteer MA, Anthony DC, Choudhury RP, Buchan AM, Sibson NR. Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 30: 1178-87. PMID 20087364 DOI: 10.1038/Jcbfm.2009.287 |
0.561 |
|
| 2010 |
Hoyte LC, Buchan AM. Animal Models of Stroke Encyclopedia of Neuroscience. 465-472. DOI: 10.1016/B978-008045046-9.00531-3 |
0.392 |
|
| 2009 |
Wu CM, Manns BJ, Hill MD, Ghali WA, Donaldson C, Buchan AM. Rapid evaluation after high-risk TIA is associated with lower stroke risk Canadian Journal of Neurological Sciences. 36: 450-455. PMID 19650355 DOI: 10.1017/S0317167100007770 |
0.371 |
|
| 2009 |
Steffenhagen N, Hill MD, Poppe AY, Buchan AM, Coutts SB. Should you thrombolyze all or any stroke patients with baseline national institutes of health stroke scale scores ≤5? Cerebrovascular Diseases. 28: 201-202. PMID 19571531 DOI: 10.1159/000226579 |
0.486 |
|
| 2009 |
Bath PM, Gray LJ, Bath AJ, Buchan A, Miyata T, Green AR. Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. British Journal of Pharmacology. 157: 1157-71. PMID 19422398 DOI: 10.1111/J.1476-5381.2009.00196.X |
0.471 |
|
| 2009 |
Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman RJ, Minematsu K, Donnan GA, Howells DW. Reprint: Good laboratory practice: preventing introduction of bias at the bench. International Journal of Stroke : Official Journal of the International Stroke Society. 4: 3-5. PMID 19236488 DOI: 10.1111/J.1747-4949.2009.00241.X |
0.326 |
|
| 2009 |
Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis Diabetes Care. 32: 617-622. PMID 19131465 DOI: 10.2337/Dc08-1754 |
0.43 |
|
| 2009 |
Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, Buchan A, van der Worp HB, Traystman RJ, Minematsu K, Donnan GA, Howells DW. Reprint: Good laboratory practice: preventing introduction of bias at the bench. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 29: 221-3. PMID 18797473 DOI: 10.1038/Jcbfm.2008.101 |
0.326 |
|
| 2009 |
Papadakis M, Buchan A. Approaches to neuroprotective and reperfusion injury therapy Handbook of Clinical Neurology / Edited by P.J. Vinken and G.W. Bruyn. 94: 1205-1223. PMID 18793896 DOI: 10.1016/S0072-9752(08)94059-8 |
0.417 |
|
| 2009 |
Chen LK, McClaran J, Buchan AM. Impact of acute stroke unit on hospital length of stay Archives of Gerontology and Geriatrics. 49: e12-e15. PMID 18789547 DOI: 10.1016/J.Archger.2008.07.008 |
0.459 |
|
| 2009 |
Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM, Buchan A, van der Worp HB, Traystman R, Minematsu K, Donnan GA, Howells DW. Good laboratory practice: preventing introduction of bias at the bench. Stroke; a Journal of Cerebral Circulation. 40: e50-2. PMID 18703798 DOI: 10.1161/Strokeaha.108.525386 |
0.324 |
|
| 2008 |
Coutts SB, Eliasziw M, Hill MD, Scott JN, Subramaniam S, Buchan AM, Demchuk AM, Fischer K, Kenney C, Ryckborst K, McClelland M, Cole-Haskayne A, Newcommon N, Werdal K, Krol A, et al. An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke International Journal of Stroke. 3: 3-10. PMID 18705908 DOI: 10.1111/J.1747-4949.2008.00182.X |
0.493 |
|
| 2008 |
Reckless I, Nagel S, Buchan A. Setting up an acute stroke service International Journal of Stroke. 3: 182-187. PMID 18705897 DOI: 10.1111/J.1747-4949.2008.00197.X |
0.457 |
|
| 2008 |
Nagel S, Papadakis M, Hoyte L, Buchan AM. Therapeutic hypothermia in experimental models of focal and global cerebral ischemia and intracerebral hemorrhage Expert Review of Neurotherapeutics. 8: 1255-1268. PMID 18671669 DOI: 10.1586/14737175.8.8.1255 |
0.486 |
|
| 2008 |
Kent DM, Buchan AM, Hill MD. The gender effect in stroke thrombolysis: Of CASES, controls, and treatment-effect modification Neurology. 71: 1080-1083. PMID 18495951 DOI: 10.1212/01.wnl.0000316191.84334.bd |
0.406 |
|
| 2008 |
Muangpaisan W, Hinkle JL, Westwood M, Kennedy J, Buchan AM. Stroke in the very old: Clinical presentations and outcomes Age and Ageing. 37: 473-475. PMID 18448466 DOI: 10.1093/Ageing/Afn210 |
0.464 |
|
| 2008 |
Papadakis M, Nagel S, Buchan AM. Development and efficacy of NXY-059 for the treatment of acute ischemic stroke Future Neurology. 3: 229-240. DOI: 10.2217/14796708.3.3.229 |
0.502 |
|
| 2007 |
Kennedy J, Buchan AM. Moving forward with intra-arterial and intravenous stroke treatment International Journal of Stroke. 2: 45-46. PMID 18705987 DOI: 10.1111/J.1747-4949.2007.00084.X |
0.478 |
|
| 2007 |
Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial Lancet Neurology. 6: 961-969. PMID 17931979 DOI: 10.1016/S1474-4422(07)70250-8 |
0.475 |
|
| 2007 |
Buchan AM, Hill MD. Is alteplase safe and effective in routine clinical practice for patients with ischemic stroke? Nature Clinical Practice. Cardiovascular Medicine. 4: 356-7. PMID 17519912 DOI: 10.1038/ncpcardio0912 |
0.403 |
|
| 2007 |
Palumbo V, Boulanger JM, Hill MD, Inzitari D, Buchan AM. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke Neurology. 68: 1020-1024. PMID 17389306 DOI: 10.1212/01.Wnl.0000257817.29883.48 |
0.467 |
|
| 2007 |
Buchan AM, Kennedy J. Strategies for therapy in acute ischemic stroke Nature Clinical Practice Neurology. 3: 2-3. PMID 17205064 DOI: 10.1038/Ncpneuro0393 |
0.516 |
|
| 2007 |
Sun HS, Feng ZP, Barber PA, Buchan AM, French RJ. Kir6.2-containing ATP-sensitive potassium channels protect cortical neurons from ischemic/anoxic injury in vitro and in vivo. Neuroscience. 144: 1509-15. PMID 17175112 DOI: 10.1016/J.Neuroscience.2006.10.043 |
0.372 |
|
| 2007 |
Dzialowski I, Pexman JHW, Barber PA, Demchuk AM, Buchan AM, Hill MD. Asymptomatic hemorrhage after thrombolysis may not be benign: Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry Stroke. 38: 75-79. PMID 17122437 DOI: 10.1161/01.Str.0000251644.76546.62 |
0.463 |
|
| 2007 |
Buchan AM, Hill MD. Is alteplase safe and effective in routine clinical practice for patients with ischemic stroke? Commentary Nature Clinical Practice Cardiovascular Medicine. 4: 356-357. DOI: 10.1038/Ncpcardio0912 |
0.499 |
|
| 2007 |
Ning MM, Montaner J, Wang X, Lee SR, Tsuji K, Tejima E, Buchan AM, Lo EH. Matrix metalloproteinases and tissue plasminogen activator reperfusion therapy for stroke Handbook of Neurochemistry and Molecular Neurobiology: Acute Ischemic Injury and Repair in the Nervous System. 269-286. DOI: 10.1007/978-0-387-30383-3_15 |
0.323 |
|
| 2006 |
Papadakis M, Buchan AM. Translational vehicles for neuroprotection Biochemical Society Transactions. 34: 1318-1322. PMID 17073811 DOI: 10.1042/Bst0341318 |
0.425 |
|
| 2006 |
Hoyte LC, Papadakis M, Barber PA, Buchan AM. Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning Brain Research. 1121: 231-237. PMID 17010948 DOI: 10.1016/J.Brainres.2006.08.107 |
0.407 |
|
| 2006 |
Muir KW, Buchan A, von Kummer R, Rother J, Baron JC. Imaging of acute stroke Lancet Neurology. 5: 755-768. PMID 16914404 DOI: 10.1016/S1474-4422(06)70545-2 |
0.405 |
|
| 2006 |
Weir NU, Pexman JHW, Hill MD, Buchan AM. How well does ASPECTS predict the outcome of acute stroke treated with IV tPA? Neurology. 67: 516-518. PMID 16894120 DOI: 10.1212/01.Wnl.0000228221.44334.73 |
0.472 |
|
| 2006 |
Hill MD, Kent DM, Hinchey J, Rowley H, Buchan AM, Wechsler LR, Higashida RT, Fischbein NJ, Dillon WP, Gent M, Firszt CM, Schulz GA, Furlan AJ. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke; a Journal of Cerebral Circulation. 37: 2322-5. PMID 16888269 DOI: 10.1161/01.Str.0000237060.21472.47 |
0.425 |
|
| 2006 |
Papadakis M, Buchan AM. NXY-059: Brain or vessel protection Stroke. 37: 2189-2190. PMID 16809574 DOI: 10.1161/01.Str.0000230598.31774.7A |
0.497 |
|
| 2006 |
Pettersen JA, Pexman JHW, Barber PA, Demchuk AM, Buchan AM, Hill MD. Insular cortical ischaemia does not independently predict acute hypertension or hyperglycaemia within 3 h of onset Journal of Neurology, Neurosurgery and Psychiatry. 77: 885-887. PMID 16788017 DOI: 10.1136/Jnnp.2005.087494 |
0.375 |
|
| 2006 |
Tomanek AI, Coutts SB, Demchuk AM, Hudon ME, Morrish WE, Sevick RJ, Simon JE, Frayne R, Buchan AM, Hill MD. MR angiography compared to conventional selective angiography in acute stroke. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 33: 58-62. PMID 16583723 DOI: 10.1017/S0317167100004704 |
0.455 |
|
| 2006 |
Rothwell PM, Buchan A, Johnston SC. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. The Lancet. Neurology. 5: 323-31. PMID 16545749 DOI: 10.1016/S1474-4422(06)70408-2 |
0.519 |
|
| 2006 |
Zhao Z, Sun P, Chauhan N, Kaur J, Hill MD, Papadakis M, Buchan AM. Neuroprotection and neurogenesis: Modulation of cornus ammonis 1 neuronal survival after transient forebrain ischemia by prior fimbria-fornix deafferentation Neuroscience. 140: 219-226. PMID 16542783 DOI: 10.1016/J.Neuroscience.2006.02.011 |
0.404 |
|
| 2006 |
Ramasubbu R, Tobias R, Buchan AM, Bech-Hansen NT. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression Journal of Neuropsychiatry and Clinical Neurosciences. 18: 96-99. PMID 16525076 DOI: 10.1176/Jnp.18.1.96 |
0.345 |
|
| 2006 |
Chen LK, Buchan AM, Hwang SJ, Hinkle J. Cataract surgery after acute stroke: Maybe more than a coincidence [10] Stroke. 37: 766-767. PMID 16505344 DOI: 10.1161/01.Str.0000204088.04384.74 |
0.444 |
|
| 2006 |
Sylaja PN, Cote R, Buchan AM, Hill MD. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study Journal of Neurology, Neurosurgery and Psychiatry. 77: 826-829. PMID 16505004 DOI: 10.1136/Jnnp.2005.086595 |
0.482 |
|
| 2006 |
Kaur J, Zhao Z, Geransar RM, Papadakis M, Buchan AM. Prior deafferentation confers long term protection to CA1 against transient forebrain ischemia and sustains GluR2 expression Brain Research. 1075: 201-212. PMID 16480690 DOI: 10.1016/J.Brainres.2005.12.123 |
0.337 |
|
| 2006 |
Buchan AM. Acute stroke treatment: The end of the first decade Practical Neurology. 6: 338-340. DOI: 10.1136/Jnnp.2006.106427 |
0.469 |
|
| 2006 |
Weir NU, Demchuk AM, Buchan AM, Hill MD. Stroke prevention | İnmeden korunma Sendrom. 18: 26-30. |
0.418 |
|
| 2005 |
Barber PA, Hill MD, Eliasziw M, Demchuk AM, Pexman JH, Hudon ME, Tomanek A, Frayne R, Buchan AM. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1528-33. PMID 16227545 DOI: 10.1136/Jnnp.2004.059261 |
0.464 |
|
| 2005 |
Kennedy J, Quan H, Buchan AM, Ghali WA, Feasby TE. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients Stroke. 36: 2072-2076. PMID 16179564 DOI: 10.1161/01.Str.0000183623.28144.32 |
0.362 |
|
| 2005 |
Barber PA, Hoyte L, Kirk D, Foniok T, Buchan A, Tuor U. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T. Neuroscience Letters. 388: 54-59. PMID 16055267 DOI: 10.1016/J.Neulet.2005.06.067 |
0.383 |
|
| 2005 |
Coutts SB, Simon JE, Eliasziw M, Sohn CH, Hill MD, Barber PA, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott JN, Buchan AM, Demchuk AM. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging Annals of Neurology. 57: 848-854. PMID 15929051 DOI: 10.1002/Ana.20497 |
0.497 |
|
| 2005 |
Weir NU, Buchan AM. A study of the workload and effectiveness of a comprehensive acute stroke service Journal of Neurology, Neurosurgery and Psychiatry. 76: 863-865. PMID 15897513 DOI: 10.1136/Jnnp.2004.053462 |
0.495 |
|
| 2005 |
Simon JE, Bristow MS, Lu H, Lauzon ML, Brown RA, Manjón JV, Eliasziw M, Frayne R, Buchan AM, Demchuk AM, Mitchell JR. A novel method to derive separate gray and white matter cerebral blood flow measures from MR imaging of acute ischemic stroke patients. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 1236-43. PMID 15889045 DOI: 10.1038/Sj.Jcbfm.9600130 |
0.448 |
|
| 2005 |
Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: Results of the Canadian Alteplase for Stroke Effectiveness Study Cmaj. 172: 1307-1312. PMID 15883405 DOI: 10.1503/Cmaj.1041561 |
0.534 |
|
| 2005 |
Sivakumar C, Palumbo V, Hill MD, Buchan AM, Bravata DM, Rosenbaum JR, Concato J, Brass LM, Kim N, Fried TR. Informed consent for thrombolytic therapy in acute ischemic stroke [3] (multiple letters) Stroke. 36: 528-529. PMID 15738575 DOI: 10.1161/01.Str.0000154854.92922.03 |
0.502 |
|
| 2005 |
Boulanger JM, Coutts SB, Hill MD, Demchuk AM, Buchan AM, Purroy F, Montaner J, Delgado P, Álvarez-Sabín J. Use of magnetic resonance imaging in predicting further vascular events among patients with transient ischemic attacks [2] (multiple letters) Stroke. 36: 526-528. PMID 15738574 DOI: 10.1161/01.Str.0000154859.25903.75 |
0.502 |
|
| 2005 |
Weir NU, Demchuk AM, Buchan AM, Hill MD. Stroke prevention: MATCHing therapy to the patient with TIA Postgraduate Medicine. 117: 26-30. PMID 15672888 DOI: 10.3810/Pgm.2005.01.1566 |
0.503 |
|
| 2005 |
Kaur J, Zhao Z, Geransar RM, Sun P, Buchan AM. Glutamate receptor subunit 2 (GluR2) expression mediates protection conferred to CA1 neurons from ischemic damage by prior fimbria-fornix deafferentation Journal of Cerebral Blood Flow & Metabolism. 25: S456-S456. DOI: 10.1038/Sj.Jcbfm.9591524.0456 |
0.317 |
|
| 2005 |
Wang R, Zhao Z, Rushforth D, Foniok T, Wamsteeker JI, Buchan A, Tomanek B, Tuor UI. Transient increases in blood pressure affect sensory-motor activation following stroke using functional MR imaging in the rat Journal of Cerebral Blood Flow & Metabolism. 25: S402-S402. DOI: 10.1038/Sj.Jcbfm.9591524.0402 |
0.388 |
|
| 2005 |
Hoyte LC, Buchan AM. Improved regional cerebral blood flow mediates tolerance afforded by ischemic preconditioning Journal of Cerebral Blood Flow & Metabolism. 25: S298-S298. DOI: 10.1038/Sj.Jcbfm.9591524.0298 |
0.374 |
|
| 2005 |
Zhao Z, Kaur J, Sun P, Hoyte L, Geransar R, Buchan A. Hypothermia following cerebral ischemia provides neuroprotection but is not beneficial toward neurogenesis Journal of Cerebral Blood Flow & Metabolism. 25: S225-S225. DOI: 10.1038/Sj.Jcbfm.9591524.0225 |
0.403 |
|
| 2004 |
Simon JE, Czechowsky DK, Hill MD, Harris AD, Buchan AM, Frayne R. Fluid-attenuated inversion recovery preparation: not an improvement over conventional diffusion-weighted imaging at 3T in acute ischemic stroke. Ajnr. American Journal of Neuroradiology. 25: 1653-8. PMID 15569726 |
0.305 |
|
| 2004 |
Coutts SB, Lev MH, Eliasziw M, Roccatagliata L, Hill MD, Schwamm LH, Pexman JH, Koroshetz WJ, Hudon ME, Buchan AM, Gonzalez RG, Demchuk AM. ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke; a Journal of Cerebral Circulation. 35: 2472-6. PMID 15486327 DOI: 10.1161/01.Str.0000145330.14928.2A |
0.405 |
|
| 2004 |
Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke Stroke. 35: 2726-2730. PMID 15459442 DOI: 10.1161/01.Str.0000143219.16695.Af |
0.477 |
|
| 2004 |
Barber PA, Demchuk AM, Hill MD, Pexman JH, Hudon ME, Frayne R, Buchan AM. The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1426-30. PMID 15377690 DOI: 10.1136/Jnnp.2003.029389 |
0.324 |
|
| 2004 |
Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM. The neurotoxicity of tissue plasminogen activator? Journal of Cerebral Blood Flow and Metabolism. 24: 945-963. PMID 15356416 DOI: 10.1097/01.Wcb.0000137868.50767.E8 |
0.357 |
|
| 2004 |
Barber PA, Foniok T, Kirk D, Buchan AM, Laurent S, Boutry S, Muller RN, Hoyte L, Tomanek B, Tuor UI. MR molecular imaging of early endothelial activation in focal ischemia Annals of Neurology. 56: 116-120. PMID 15236408 DOI: 10.1002/Ana.20162 |
0.346 |
|
| 2004 |
Barber PA, Hoyte L, Colbourne F, Buchan AM. Temperature-regulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes. Stroke; a Journal of Cerebral Circulation. 35: 1720-5. PMID 15155973 DOI: 10.1161/01.Str.0000129653.22241.D7 |
0.394 |
|
| 2004 |
Coutts SB, Demchuk AM, Barber PA, Hu WY, Simon JE, Buchan AM, Hill MD. Interobserver variation of ASPECTS in real time Stroke; a Journal of Cerebral Circulation. 35: e103-105. PMID 15073381 DOI: 10.1161/01.Str.0000127082.19473.45 |
0.444 |
|
| 2004 |
Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJ. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 170: 1105-9. PMID 15051694 DOI: 10.1503/Cmaj.1030460 |
0.492 |
|
| 2004 |
Pexman JHW, Hill MD, Buchan AM, Demchuk AM, Barber PA, Simon JE, Coutts SB, Saur D, Röther J, Kucinski T. Hyperacute Stroke: Experience Essential When Reading Unenhanced CT Scans American Journal of Neuroradiology. 25: 516-518. PMID 15037484 |
0.316 |
|
| 2004 |
Hoyte L, Barber PA, Buchan AM, Hill MD. The rise and fall of NMDA antagonists for ischemic stroke Current Molecular Medicine. 4: 131-136. PMID 15032709 DOI: 10.2174/1566524043479248 |
0.412 |
|
| 2004 |
Simon JE, Sandler DL, Pexman JHW, Hill MD, Buchan AM. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke? - The Calgary experience Age and Ageing. 33: 143-149. PMID 14960429 DOI: 10.1093/Ageing/Afh031 |
0.464 |
|
| 2004 |
Di Legge S, Beletsky V, Jain V, Hachinski V, Simon JE, Morgan SC, Pexman JHW, Hill MD, Buchan AM. CT assessment of conjugate eye deviation in acute stroke [1] (multiple letters) Neurology. 62: 523. PMID 14872055 DOI: 10.1212/WNL.62.3.523 |
0.307 |
|
| 2004 |
Kennedy J, Buchan AM. Acute Neurovascular Syndromes: Hurry Up, Please, It's Time Stroke. 35: 360-362. PMID 14757879 DOI: 10.1161/01.Str.0000115260.19243.64 |
0.512 |
|
| 2004 |
Coutts SB, Barber PA, Demchuk AM, Hill MD, Pexman JHW, Hudon ME, Buchan AM. Mild Neurological Symptoms Despite Middle Cerebral Artery Occlusion Stroke. 35: 469-471. PMID 14726548 DOI: 10.1161/01.Str.0000110985.01773.7F |
0.532 |
|
| 2004 |
Kennedy J, Ma C, Buchan AM. Organization of regional and local stroke resources: Methods to expedite acute management of stroke Current Neurology and Neuroscience Reports. 4: 13-18. PMID 14683622 DOI: 10.1007/S11910-004-0005-9 |
0.504 |
|
| 2003 |
Coutts SB, Hill MD, Demchuk AM, Barber PA, Pexman JHW, Buchan AM. ASPECTS reading requires training and experience Stroke; a Journal of Cerebral Circulation. 34: e179; author reply e. PMID 12970512 DOI: 10.1161/01.Str.0000092221.81498.91 |
0.336 |
|
| 2003 |
Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke; a Journal of Cerebral Circulation. 34: 1925-31. PMID 12843342 DOI: 10.1161/01.Str.0000082483.37127.D0 |
0.511 |
|
| 2003 |
Coutts SB, Simon JE, Tomanek AI, Barber PA, Chan J, Hudon ME, Mitchell JR, Frayne R, Eliasziw M, Buchan AM, Demchuk AM. Reliability of assessing percentage of diffusion-perfusion mismatch. Stroke; a Journal of Cerebral Circulation. 34: 1681-3. PMID 12805485 DOI: 10.1161/01.Str.0000078840.96473.20 |
0.369 |
|
| 2003 |
Barber PA, Demchuk AM, Hirt L, Buchan AM. Biochemistry of ischemic stroke Advances in Neurology. 92: 151-164. PMID 12760178 |
0.435 |
|
| 2003 |
Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, Green TL, Kenney C, Cole-Haskayne A, Buchan AM. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke Neurology. 60: 1525-1527. PMID 12743244 DOI: 10.1212/01.Wnl.0000058840.66596.1A |
0.452 |
|
| 2003 |
Watson TW, Simon JE, Buchan AM. Stroke care: the way forward. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 411-2. PMID 12640048 DOI: 10.1136/Jnnp.74.4.411 |
0.522 |
|
| 2003 |
Colbourne F, Grooms SY, Zukin RS, Buchan AM, Bennett MV. Hypothermia rescues hippocampal CA1 neurons and attenuates down-regulation of the AMPA receptor GluR2 subunit after forebrain ischemia. Proceedings of the National Academy of Sciences of the United States of America. 100: 2906-10. PMID 12606709 DOI: 10.1073/Pnas.2628027100 |
0.313 |
|
| 2003 |
Kennedy J, Buchan AM. Ever decreasing circles: Advances in antiplatelet therapy and anticoagulation Stroke. 34: 348-350. PMID 12574532 DOI: 10.1161/01.Str.0000054264.39521.56 |
0.498 |
|
| 2003 |
Chauhan N, Zhao Z, Barber PA, Buchan AM. Lessons in experimental ischemia for clinical stroke medicine Current Opinion in Neurology. 16: 65-71. PMID 12544859 DOI: 10.1097/01.Wco.0000053588.70044.5A |
0.479 |
|
| 2003 |
Simon JE, Morgan SC, Pexman JH, Hill MD, Buchan AM. CT assessment of conjugate eye deviation in acute stroke. Neurology. 60: 135-7. PMID 12525738 DOI: 10.1212/01.Wnl.0000042086.98735.75 |
0.416 |
|
| 2003 |
KENNEDY J, ELIASZIW M, HILL M, BUCHAN A. The fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER) trial Seminars in Cerebrovascular Diseases and Stroke. 3: 25-30. DOI: 10.1053/Scds.2003.00009 |
0.491 |
|
| 2002 |
Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR, Hamilton SA, Hanson SK, Grotta JC, Morgenstern L, Krieger D, Villar C, Chiu D, Wein T, ... ... Buchan AM, et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: The multicenter rt-PA acute stroke survey Circulation. 105: 1679-1685. PMID 11940547 DOI: 10.1161/01.CIR.0000012747.53592.6A |
0.435 |
|
| 2002 |
Hill MD, Barber PA, Demchuk AM, Newcommon NJ, Cole-Haskayne A, Ryckborst K, Sopher L, Button A, Hu W, Hudon ME, Morrish W, Frayne R, Sevick RJ, Buchan AM. Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke. Stroke; a Journal of Cerebral Circulation. 33: 279-82. PMID 11779923 DOI: 10.1161/Hs0102.101900 |
0.497 |
|
| 2001 |
Hill MD, Gubitz GJ, Phillips SJ, Buchan AM. Thrombolytic therapy for acute ischemic stroke - The CAEP Position Statement: another perspective. Cjem. 3: 180-2. PMID 17610780 DOI: 10.1017/S1481803500005509 |
0.461 |
|
| 2001 |
Kennedy J, Buchan AM, Barnett HJ. Thrombolysis must be considered after stroke. Bmj (Clinical Research Ed.). 323: 937. PMID 11668151 DOI: 10.1136/Bmj.323.7318.937/B |
0.499 |
|
| 2001 |
Pexman JHW, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, Hu WY, Buchan AM. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke American Journal of Neuroradiology. 22: 1534-1542. PMID 11559501 |
0.321 |
|
| 2001 |
Hill MD, Buchan AM. Methodology for the Canadian Activase for Stroke Effectiveness Study (CASES) Canadian Journal of Neurological Sciences. 28: 232-238. PMID 11513342 DOI: 10.1017/S0317167100001384 |
0.506 |
|
| 2001 |
Zhao Z, Cheng M, Maples KR, Ma JY, Buchan AM. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat Brain Research. 909: 46-50. PMID 11478919 DOI: 10.1016/S0006-8993(01)02618-X |
0.332 |
|
| 2001 |
Buchan A. Aspects of stroke imaging. Canadian Journal of Neurological Sciences. 28: 99-100. PMID 11383947 DOI: 10.1017/S0317167100052744 |
0.466 |
|
| 2001 |
Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 56: 1015-20. PMID 11320171 DOI: 10.1212/WNL.56.8.1015 |
0.373 |
|
| 2001 |
Barber PA, Auer RN, Buchan AM, Sutherland GR. Understanding and managing ischemic stroke. Canadian Journal of Physiology and Pharmacology. 79: 283-96. PMID 11294605 DOI: 10.1139/Y00-125 |
0.477 |
|
| 2001 |
Buchan AM, Warren D, Burnstein R, Kondziolka D. Transplantation of cultured human neuronal cells for patients with stroke [2] Neurology. 56: 821-822. PMID 11274333 DOI: 10.1212/Wnl.56.6.820-A |
0.313 |
|
| 2001 |
Hill MD, Barber PA, Demchuk AM, Sevick RJ, Frayne R, Buchan AM. Symptomatic hemorrhage after alteplase therapy not due to silent ischemia. Bmc Neurology. 1: 1. PMID 11208259 DOI: 10.1186/1471-2377-1-1 |
0.542 |
|
| 2001 |
Li H, Klein G, Sun P, Buchan AM. Dehydroepiandrosterone (DHEA) reduces neuronal injury in a rat model of global cerebral ischemia Brain Research. 888: 263-266. PMID 11150483 DOI: 10.1016/S0006-8993(00)03077-8 |
0.327 |
|
| 2001 |
Barber PA, Demchuk AM, Hudon ME, Warwick Pexman JH, Hill MD, Buchan AM. Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia Stroke. 32: 84-88. PMID 11136919 DOI: 10.1161/01.Str.32.1.84 |
0.474 |
|
| 2001 |
Hill MD, Newcommon N, Barber PA, Demchuk AM, Buchan AM. Intra-arterial therapy following intravenous alteplase for severe ischemic stroke Stroke. 32: 374-374. DOI: 10.1161/01.Str.32.Suppl_1.374 |
0.474 |
|
| 2001 |
Barber PA, Zhang J, Demchuk AM, Hill MD, Cole-Haskayne A, Newcommon N, Virji H, Buchan AM. Why stroke patients don't receive t-PA? An analysis of patient eligibility: Implications for improving clinical impact by increasing future treatment numbers Stroke. 32: 372-372. DOI: 10.1161/01.Str.32.Suppl_1.372-D |
0.514 |
|
| 2001 |
Barber PA, Demchuk AM, Hudon ME, Pexman W, Hill MD, Buchan AM. The hyperdense sylvian fissure MCA "dot" sign: a marker of acute CT ischemia Stroke. 32: 346-346. DOI: 10.1161/01.Str.32.Suppl_1.346-B |
0.454 |
|
| 2001 |
Barber PA, Demchuk AM, Hill MD, Pexman W, Hudon ME, Tomanek A, Beaupre D, Frayne R, Buchan AM. A comparison of CT versus MR imaging in acute stroke using ASPECTS: Will the “new” replace the “old” as the preferred imaging modality? Stroke. 32: 325-325. DOI: 10.1161/01.Str.32.Suppl_1.325 |
0.46 |
|
| 2001 |
Hill MD, Buchan AM. The Canadian Activase for Stroke Effectiveness Study (CASES): Interim results Stroke. 32: 323-323. DOI: 10.1161/01.Str.32.Suppl_1.323-A |
0.532 |
|
| 2001 |
Hill, Barber PA, Demchuk AM, Pexman W, Buchan AM, Investigators C. Baseline ASPECT Scores predict extent of stroke: Interim CT Analysis of CASES Stroke. 32: 319-320. DOI: 10.1161/01.Str.32.Suppl_1.319-D |
0.371 |
|
| 2001 |
Warren DT, Buchan AM. Cerebral Ischemia: Molecular and Cellular Pathophysiology. 1st Edition. 1999. Edited by Wolfgang Walz. Published by Humana Press Inc. 278 pages. C$181.25 approx. Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 28: 380-380. DOI: 10.1017/S0317167100019260 |
0.323 |
|
| 2000 |
Buchan AM, Feasby TE. Stroke thrombolysis: Is tissue plasminogen activator a defibrillator for the brain? Cmaj. 162: 47-48. PMID 11216198 |
0.348 |
|
| 2000 |
Colbourne F, Corbett D, Zhao Z, Yang J, Buchan AM. Prolonged but delayed postischemic hypothermia: a long-term outcome study in the rat middle cerebral artery occlusion model. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 20: 1702-8. PMID 11129786 DOI: 10.1097/00004647-200012000-00009 |
0.38 |
|
| 2000 |
Barber PA, Hill MD, Demchuk AM, Buchan AM. Doubts, fears and misconceptions. What is the future of thrombolysis in acute stroke? Canadian Journal of Neurological Sciences. 27: 283-287. PMID 11097516 DOI: 10.1017/S0317167100001001 |
0.513 |
|
| 2000 |
Small DL, Buchan AM. Animal models. British Medical Bulletin. 56: 307-17. PMID 11092082 DOI: 10.1258/0007142001903238 |
0.412 |
|
| 2000 |
MacManus JP, Buchan AM. Apoptosis after experimental stroke: Fact or fashion? Journal of Neurotrauma. 17: 899-914. PMID 11063056 DOI: 10.1089/Neu.2000.17.899 |
0.43 |
|
| 2000 |
Nawashiro H, Fukui S, Barber PA, Demchuk AM, Buchan AM. Intra-arterial thrombolysis for hyperacute stroke [5] (multiple letters) Lancet. 356: 1111-1112. PMID 11009167 |
0.388 |
|
| 2000 |
Li H, Klein G, Sun P, Buchan AM. CoQ10 fails to protect brain against focal and global ischemia in rats Brain Research. 877: 7-11. PMID 10980237 DOI: 10.1016/S0006-8993(00)02609-3 |
0.411 |
|
| 2000 |
Hill MD, Barber PA, Demchuk AM, Buchan AM, Bath P, Bath F, Rashid P, Weaver C. Acute ischaemic stroke (multiple letters) British Medical Journal. 321: 299-300. PMID 10979695 |
0.411 |
|
| 2000 |
Chodirker WB, Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Reactions to alteplase in patients with acute thrombotic stroke [2] (multiple letters) Cmaj. 163: 387-389. PMID 10976251 |
0.366 |
|
| 2000 |
Buchan AM. Can pure oxygen prevent stroke damage? Critical Care Medicine. 28: 3101. PMID 10966313 DOI: 10.1097/00003246-200008000-00081 |
0.465 |
|
| 2000 |
Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy Lancet. 355: 1670-1674. PMID 10905241 DOI: 10.1016/S0140-6736(00)02237-6 |
0.46 |
|
| 2000 |
Barnett HJ, Buchan AM. The imperative to develop dedicated stroke centers. Jama. 283: 3125-6. PMID 10865309 DOI: 10.1001/Jama.283.23.3125 |
0.525 |
|
| 2000 |
Hill MD, Barber PA, Demchuk AM, Sevick RJ, Newcommon NJ, Green T, Buchan AM. Building a 'brain attack' team to administer thrombolytic therapy for acute ischemic stroke Cmaj. 162: 1589-1593. PMID 10862236 |
0.434 |
|
| 2000 |
Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke Cmaj. 162: 1281-1284. PMID 10813008 |
0.367 |
|
| 2000 |
Demchuk AM, Buchan AM. Predictors of stroke outcome Neurologic Clinics. 18: 455-473. PMID 10757836 DOI: 10.1016/S0733-8619(05)70202-4 |
0.436 |
|
| 2000 |
Buchan AM, Barber PA, Newcommon N, Karbalai HG, Demchuk AM, Hoyte KM, Klein GM, Feasby TE. Effectiveness of t-PA in acute ischemic stroke: Outcome relates to appropriateness Neurology. 54: 679-684. PMID 10680803 DOI: 10.1212/Wnl.54.3.679 |
0.508 |
|
| 2000 |
Buchan AM, Li H, Blackburn B. Neuroprotection achieved with a novel proteasome inhibitor which blocks NF-κB activation Neuroreport. 11: 427-430. PMID 10674500 DOI: 10.1097/00001756-200002070-00041 |
0.386 |
|
| 2000 |
Li H, Colbourne F, Sun P, Zhao Z, Buchan AM, Iadecola C. Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke; a Journal of Cerebral Circulation. 31: 176-82. PMID 10625735 DOI: 10.1161/01.Str.31.1.176 |
0.39 |
|
| 2000 |
Barber PA, Demchuk AM, Buchan AM. Intra-arterial thrombolysis for hyperacute stroke The Lancet. 356: 1112. DOI: 10.1016/S0140-6736(05)74554-2 |
0.488 |
|
| 2000 |
Verbeek R, Buchan AM, Feasby TE. Treating stroke [1] (multiple letters) Cmaj. 162: 1273-1274. |
0.42 |
|
| 2000 |
Hill MD, Barber PA, Demchuk AM, Buchan AM. Time is brain: Post-marketing experience with alteplase (tPA) for acute ischemic stroke Today's Therapeutic Trends. 18: 285-304. |
0.368 |
|
| 1999 |
Small DL, Morley P, Buchan AM. Biology of ischemic cerebral cell death. Progress in Cardiovascular Diseases. 42: 185-207. PMID 10598920 DOI: 10.1016/S0033-0620(99)70002-2 |
0.487 |
|
| 1999 |
Huang ZG, Xue D, Preston E, Karbalai H, Buchan AM. Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 26: 298-304. PMID 10563216 DOI: 10.1017/S0317167100000421 |
0.328 |
|
| 1999 |
Scott JN, Buchan AM, Sevick RJ. Correlation of neurologic dysfunction with CT findings in early acute stroke. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 26: 182-9. PMID 10451740 DOI: 10.1017/S0317167100000226 |
0.471 |
|
| 1999 |
Colbourne F, Li H, Buchan AM. Indefatigable CA1 sector neuroprotection with mild hypothermia induced 6 hours after severe forebrain ischemia in rats. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 742-9. PMID 10413028 DOI: 10.1097/00004647-199907000-00003 |
0.339 |
|
| 1999 |
Klein GM, Li H, Sun P, Buchan AM. Tissue plasminogen activator does not increase neuronal damage in rat models of global and focal ischemia. Neurology. 52: 1381-4. PMID 10227621 DOI: 10.1212/Wnl.52.7.1381 |
0.452 |
|
| 1999 |
Colbourne F, Li H, Buchan AM, Clemens JA. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke; a Journal of Cerebral Circulation. 30: 662-8. PMID 10066868 DOI: 10.1161/01.Str.30.3.662 |
0.332 |
|
| 1999 |
Demchuk AM, Morgenstern LB, Krieger DW, Linda Chi T, Hu W, Wein TH, Hardy RJ, Grotta JC, Buchan AM. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 30: 34-9. PMID 9880385 DOI: 10.1161/01.Str.30.1.34 |
0.489 |
|
| 1998 |
Norris JW, Buchan A, Cote R, Hachinski V, Phillips SJ, Shuaib A, Silver F, Simard D, Teal P. Canadian guidelines for intravenous thrombolytic treatment in acute stroke: A consensus statement of the canadian stroke consortium Canadian Journal of Neurological Sciences. 25: 257-259. PMID 9706731 DOI: 10.1017/S0317167100034120 |
0.494 |
|
| 1997 |
Hou ST, Tu Y, Buchan AM, Huang Z, Preston E, Rasquinha I, Robertson GS, MacManus JP. Increases in DNA lesions and the DNA damage indicator Gadd45 following transient cerebral ischemia. Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 75: 383-92. PMID 9493961 DOI: 10.1139/O97-059 |
0.324 |
|
| 1997 |
Small DL, Poulter MO, Buchan AM, Morley P. Alteration in NMDA receptor subunit mRNA expression in vulnerable and resistant regions of in vitro ischemic rat hippocampal slices. Neuroscience Letters. 232: 87-90. PMID 9302093 DOI: 10.1016/S0304-3940(97)00592-2 |
0.308 |
|
| 1997 |
Lingenhöhl K, Small DL, Monette R, Buchan AM, Morley P, Allegrini PR, Fröst LW, Sauer D, Schmutz M, Knöpfel T. Exploration of P-type Ca2+ channels as drug targets for the treatment of epilepsy or ischemic stroke. Neuropharmacology. 36: 107-13. PMID 9144647 DOI: 10.1016/S0028-3908(96)00158-X |
0.401 |
|
| 1997 |
Kozlowski P, Buchan AM, Tuor UI, Xue D, Huang Z, Chaundy KE, Saunders JK. Effect of temperature in focal ischemia of rat brain studied by 31P and 1H spectroscopic imaging. Magnetic Resonance in Medicine. 37: 346-354. PMID 9055223 DOI: 10.1002/Mrm.1910370307 |
0.363 |
|
| 1997 |
Small DL, Buchan AM. NMDA antagonists: their role in neuroprotection. International Review of Neurobiology. 40: 137-71. PMID 8989620 DOI: 10.1016/S0074-7742(08)60719-9 |
0.334 |
|
| 1996 |
Small DL, Buchan AM. Mechanisms of cerebral ischemia: intracellular cascades and therapeutic interventions. Journal of Cardiothoracic and Vascular Anesthesia. 10: 139-46. PMID 8634379 DOI: 10.1016/S1053-0770(96)80189-3 |
0.368 |
|
| 1994 |
Takizawa S, Hogan MJ, Buchan AM, Hakim AM. In vivo binding of [3H]nimodipine in rat brain after transient forebrain ischemia Journal of Cerebral Blood Flow and Metabolism. 14: 397-405. PMID 8163582 DOI: 10.1038/Jcbfm.1994.51 |
0.324 |
|
| 1994 |
MacManus JP, Buchan AM, Hill IE, Rasquinha I, Preston E. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neuroscience Letters. 164: 89-92. PMID 8152622 DOI: 10.1016/0304-3940(93)90864-H |
0.361 |
|
| 1994 |
Buchan AM, Gertler SZ, Li H, Xue D, Huang ZG, Chaundy KE, Barnes K, Lesiuk HJ. A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 903-10. PMID 7929655 DOI: 10.1038/Jcbfm.1994.121 |
0.378 |
|
| 1994 |
Buchan AM, Gertler SZ, Huang ZG, Li H, Chaundy KE, Xue D. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase. Neuroscience. 61: 1-11. PMID 7526264 DOI: 10.1016/0306-4522(94)90054-X |
0.365 |
|
| 1994 |
Xue D, Huang ZG, Barnes K, Lesiuk HJ, Smith KE, Buchan AM. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 251-61. PMID 7509339 DOI: 10.1038/Jcbfm.1994.32 |
0.351 |
|
| 1993 |
Pulsinelli W, Sarokin A, Buchan A. Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia. Progress in Brain Research. 96: 125-35. PMID 8392737 DOI: 10.1016/S0079-6123(08)63262-8 |
0.39 |
|
| 1993 |
Buchan AM, Lesiuk H, Barnes KA, Li H, Huang ZG, Smith KE, Xue D. AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists? Stroke; a Journal of Cerebral Circulation. 24: I148-52. PMID 7504338 |
0.309 |
|
| 1993 |
Stenerson PE, Buchan AM. Recent advances in the treatment of acute ischemic stroke Current Opinion in Orthopaedics. 4: 23-28. DOI: 10.1097/00001433-199310000-00006 |
0.415 |
|
| 1992 |
Buchan AM, Li H, Cho S, Pulsinelli WA. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neuroscience Letters. 132: 255-8. PMID 1664505 DOI: 10.1016/0304-3940(91)90314-J |
0.317 |
|
| 1992 |
Xue D, Slivka A, Buchan AM. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Stroke. 23: 894-9. PMID 1595111 DOI: 10.1161/01.Str.23.6.894 |
0.378 |
|
| 1992 |
Buchan AM, Xue D, Slivka A. A new model of temporary focal neocortical ischemia in the rat. Stroke. 23: 273-9. PMID 1561658 DOI: 10.1161/01.Str.23.2.273 |
0.309 |
|
| 1992 |
Xue D, Huang ZG, Smith KE, Buchan AM. Immediate or delayed mild hypothermia prevents focal cerebral infarction. Brain Research. 587: 66-72. PMID 1525650 DOI: 10.1016/0006-8993(92)91428-H |
0.37 |
|
| 1992 |
Buchan AM, Slivka A, Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Research. 574: 171-7. PMID 1386274 DOI: 10.1016/0006-8993(92)90814-P |
0.411 |
|
| 1992 |
Buchan A. Advances in Cerebral Ischemia: Experimental Approaches Neurologic Clinics. 10: 49-61. DOI: 10.1016/S0733-8619(18)30233-0 |
0.448 |
|
| 1991 |
Buchan AM, Xue D, Huang ZG, Smith KH, Lesiuk H. Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia. Neuroreport. 2: 473-6. PMID 1655110 DOI: 10.1097/00001756-199108000-00016 |
0.39 |
|
| 1991 |
Buchan A, Li H, Pulsinelli WA. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. The Journal of Neuroscience. 11: 1049-1056. DOI: 10.1523/Jneurosci.11-04-01049.1991 |
0.319 |
|
| 1990 |
Buchan AM, Pulsinelli WA. Septo-hippocampal deafferentation protects CA1 neurons against ischemic injury. Brain Research. 512: 7-14. PMID 2337809 DOI: 10.1016/0006-8993(90)91163-B |
0.338 |
|
| 1990 |
Buchan A, Pulsinelli W. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia The Journal of Neuroscience. 10: 311-316. DOI: 10.1523/Jneurosci.10-01-00311.1990 |
0.337 |
|
| 1988 |
Buchan A, Gates P, Pelz D, Barnett HJ. Intraluminal thrombus in the cerebral circulation. Implications for surgical management. Stroke. 19: 681-7. PMID 3376159 DOI: 10.1161/01.Str.19.6.681 |
0.371 |
|
| 1986 |
Pelz DM, Buchan A, Fox AJ, Barnett HJ, Vinuela F. Intraluminal thrombus of the internal carotid arteries: angiographic demonstration of resolution with anticoagulant therapy alone. Radiology. 160: 369-73. PMID 3726115 DOI: 10.1148/Radiology.160.2.3726115 |
0.32 |
|
| 1982 |
Buchan A. Fundamentals of neurology Journal of the Neurological Sciences. 56: 132. DOI: 10.1016/0022-510X(82)90072-7 |
0.347 |
|
| Show low-probability matches. |